Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustainable Green Team ...

From established players to up-and-coming firms, Canada's pharmaceutical company landscape is diverse and dynamic. Canadian drug companies are working to discover and develop major innovations amidst ...

NRx Pharmaceuticals (NASDAQ: NRXP) , announced that CEO and Chairman Prof. Jonathan Javitt, MD, MPH will participate in a fireside chat at the BTIG V ...

NRx Pharmaceuticals (NASDAQ: NRXP), announced that CEO and Chairman Prof. Jonathan Javitt, MD, MPH will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on July 29–30, 2025.

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), today announced that its CEO and Chairman ...

This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing innovative treatments for suicidal ...

NRx Pharmaceuticals (NASDAQ: NRXP) , a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, is ...

NRx Pharmaceuticals NRXP, a clinical-stage biopharmaceutical company, is executing a dual growth strategy focused on expanding its national network of mental health clinics through its subsidiary ...

Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.

NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal ...